ORGANOGENESIS HOLDINGS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.97 USD | +4.39% |
|
+28.57% | -27.38% |
| 05-13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
| 05-10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 394M | - | |||||
| 49.46B | - | |||||
| 42.58B | ||||||
| 42.49B | ||||||
| 29.09B | ||||||
| 26.61B |
